宫颈病变中错配修复基因hMLH1、hMSH2的表达及意义(2)
 |
| 第1页 |
参见附件。
参考文献
[1]许良中，杨文涛.免疫组织化学反应结果的判断. 中国癌症杂志，1996，6(4):229-231.
[2]Chao EC,Lipkin SM.Molecular models for the tissue specificity of DNA mismatch repair deficient carcinogenesis.Nucleic Acids Res，2006，34(3): 840-852.
[3]Ciavattini A，Piccioni M.Immunohistochemical expression of DNA mismatch repair (MMR) system proteins (hMLH1,hMSH2)in cervical preinvasive and invasive lesions.Pathology Research and Practice,2005,(201):21-25.
[4]DONG Li ,WANG Wen,WANG Li.Expression of human mismatch repair gene(hMLH1/hMSH2) and p53 overexpression in endometrial carcinoma and its significance.Practical Pharmacy And Clinical Remedies,2007,10(2)：71-73.
[5]Chialina SG,Fornes C,Landi C,et al.Microsatellite instability analysis in hereditary non - polyposis colon cancer using the Bethesda consensus panel of microsatellite markers in the absence of proband normal tissue. BMC Med Genet,2006(7):5.
[6]Kamory E,Kolacsek O,Otto S,et al.hMLH1 and hMSH2 somatic inactivation mechanisms in sporadic colorectal cancer patients.Patholoncol Res.2003,9(4):236-240.
[7]Ciavattini A,Piccioni M,Tranquilli AL,et al.Immunohistochemical expression of DNA mismatch repair (MMR) system proteins (hMLH1, hMSH2) in cervical preinvasive and invasive lesions.Pathology Research and Practice,2005,201(1):21-25.
[8]张连民,边爱平,赵旭.Fhit、Survivin基因在宫颈病变中的表达与高危型HPV感染的相关性研究.中国医学创新，2010，7(2):60-62.
【收稿日期】2011-08-10
您现在查看是摘要介绍页，详见PDF附件。